Consistent with this view, vascular endothelial growth factor expression at the invading tumour front is reported to be 4–10 times higher than in the inner tumour areas and is significantly associated with poor prognosis, particularly within stage I endometrial cancer (Abulafia et al, 1999; Bristow, 1999). The gene discussed is VEGFA; the disease is neoplasm.